You must be 21 years old and above to access RxLeaf

Is Cannabis an Antibiotic? 

Marc Moulin
is cannabis an antibiotic Petri dish experiment

The antibiotic potential of cannabis needs human clinical trials. 

A Centers for Disease Control report says that antibiotic-resistant bacteria and fungi are responsible for 35,000 deaths in the United States each year. Accordingly, the associated economic costs are massive. In a study published in Pharmaceuticals and Medical Technology (2018), the researchers estimated that antibiotics resistance added $1,383 to the cost of treating a patient with a bacterial infection. Figuring in the number of infections in just 2014, the total cost tops $2.2 billion per year.

Fortunately, the problem is easy enough to understand. Essentially, doctors can’t treat antibiotic-resistant infections with antibiotics to which these were once sensitive. Subsequently, the medical community needs novel antibiotic treatments to combat these infections. In an era of growing medical interest in the efficacy of cannabis to treat a broad spectrum of physical and mental ailments, it might not come as a surprise that cannabis researchers are targeting antibiotic-resistant infections with cannabinoids. However, this is not the first time that researchers have studied whether cannabis is an antibiotic.

In Vitro Cannabinoid-Antibiotic Success

Investigations into the antibiotic potential of cannabis are not new. In 1976, researchers detailed that cannabis inhibits the growth of bacteria in vitro (in a laboratory setting outside of a living organism). However, over the years, in vitro investigations into cannabis’ antibacterial properties have continued, and diversified across a wider array of cannabinoids including cannabidiol (CBD), cannabichromene (CBC), delta-9 tetrahydrocannabinol (THC), and cannabinol (CBN).

In a study published in the Journal of Natural Products (2008), the researchers also found that five major cannabinoids showed powerful activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains. Certainly, if cannabis could act as a new antimicrobial treatment in highly resistant bacterial strains in humans, that would be a big win for healthcare. The human body, however, isn’t a petri dish.

The question “is cannabis an antibiotic?” can only be answered after moving well beyond in vitro studies. Thankfully, Canadian researchers have taken the first step.

question of Is Cannabis an Antibiotic represented by scientist working with cultures in a petri dish

 In Vivo Cannabinoid-Antibiotic Success

Researchers from McMaster University built upon previous research. Recently, the McMaster scientists executed one of the first in vivo research studies to test cannabis as an antibiotic. The research team tested several cannabinoids in mice, including a synthetic form of CBG. Across multiple trials, CBG demonstrated the greatest antibacterial potential. Amazingly, CBG treated MRSA as effectively as an antibiotic called vancomycin, which is commonly provided to fight against antibiotic-resistant bacteria in the gut. As a result, their findings were recently published in bioRxiv (2020).

The researchers showed that cannabinoids exhibit antibacterial activity against MRSA. The antibacterial action works because the cannabinoids stop the MRSA from forming new biofilms, and destroy pre-formed biofilms. The exact mechanism of action is a targeting of the cytoplasmic membrane of Gram-positive bacteria. However, the researchers also found success against Gram-negative bacteria, unlike the 1976 in vitro studies mentioned earlier.

Gram-negative bacteria are more difficult to treat because they have a more protective cell wall. The researchers combined the cannabinoids with a chemical called polymyxin B. The drug cocktail destroyed the multi-resistant Gram-negative bacteria. Further, the authors concluded that their findings reveal the wide-spread therapeutic potential for cannabinoids in the fight against antibiotic-resistant organisms, and warrant further research and optimization.

Why do Cannabis Plants Contain Antibiotic Compounds?

Cannabis plants are particularly rich in antibiotic compounds. However, this does not necessarily make them unique compared to other plant species. Mark Blaskovich, who studies antibiotic cannabis compounds at the University of Queensland, notes that tea tree, garlic, and some spices also contain antibacterial compounds. Blaskovich says, “These are likely made as a defence mechanism to protect the plant from bacterial and fungi infections.”

Unfortunately, Blaskovich also notes that these compounds, “have not been very useful for human infections as they really only work outside the body.” However, that’s, “what makes this new report potentially exciting – evidence that cannabigerol (CBG) is able to treat a systemic infection in mice.” Remember, though, that this is only the beginning stage of ongoing research.

question of Is Cannabis an Antibiotic represented by gloved hand holding up petri dish

Establishing Confidence Through Human Trials

The McMaster study is preclinical evidence. Although CBG had success in treating antibiotic-resistant bacteria in mice, this doesn’t provide any evidence for its effectiveness in humans.

Additionally, the researchers found that in high doses, CBG damaged healthy human cells. According to Eric Brown, one of the McMaster researchers, the next step is to modify the CBG compound, and perhaps combine it with another substance to reduce toxicity. Researchers must establish the safety of a drug before wide-spread human trials can occur.

Is Cannabis an Antibiotic for Humans?

Without clinical evidence, there is no definitive answer. The road to human trials is long but necessary to give confidence in the safety and effectiveness of treatment. Thankfully, these preliminary studies give a reason for optimism. Antibiotics are one of the greatest achievements in modern medicine, but over-prescription increases antibiotic resistance.

If cannabis can successfully treat these infections in humans, the medical community might have the novel antimicrobial treatment that they have been searching for.


Thorpe, K. E., Joski, P., & Johnston, K. J. (2018). Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Affairs37(4), 662-669.
Van Klingeren, B. & Ten Ham, M. (1976). Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol. Antonie Van Leeuwenhoek, 42(1-2), 9-12.
Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., Stavri, M., … & Rahman, M. M. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure− activity study. Journal of Natural products71(8), 1427-1430.
Farha, M. A., El-Halfawy, O. M., Gale, R. T., MacNair, C. R., Carfrae, L. A., Zhang, X., … & Brown, E. D. (2020). Uncovering the hidden antibiotic potential of Cannabis. BioRxiv, 833392.

Marc Moulin
  • Avatar
    Jacque Knight

    So where is the recipe for making hard candy what the heck

    March 23, 2020 at 2:47 pm Reply
  • Avatar
    Bill Rhodes

    I have lots of pain, I’m a liver Transplant case . As you may know there are not any pain meds I can take so this would be a good send to have edibles ,unfortunately I live in Kansas close to the Missouri border . If I could get a doctor to prescribe it I would cross the border to get it . Have any suggestions ?

    March 23, 2020 at 4:58 pm Reply
    • Jennifer Grant

      Please make sure that Missouri and Kansas have that agreement because crossing state lines with cannabis is a crime. You could Google search a doctor in Missouri that is willing to see you.

      March 24, 2020 at 10:30 am Reply
    • Avatar
      Sherry Gennaro

      A Dr won’t prescribe. You will need to buy on your own. Insurance does not pay for anything BIG PHARMA isn’t involved in.

      Just buy your self get the RSO

      April 27, 2020 at 7:49 am Reply
  • Avatar
    Karen Buchko

    Start doing clinical trials on humans smokers verses non smokers dabers verses non dabbers and so on duh……

    March 24, 2020 at 9:56 am Reply
  • Avatar
    Emily Lowrance

    The virus is a non-living organism. Antibiotics don’t touch it very well. But they could potentially help with respiratory infections that happen as a result of the virus. This is something that needs clinical trials. If there are anecdotes of experience where it’s helped with an infection. It would be on Erowid Vault

    April 6, 2020 at 12:52 am Reply
    • Jennifer Grant

      At this point, studies are limited to MRSA and other antibiotic-resistant bacteria. And these have been done in the lab only.

      April 6, 2020 at 9:24 am Reply

Post a Comment